Zur Rose Group
Online pharmacy and medical products supplier.
Launch date
Employees
Market cap
AUD679m
Enterprise valuation
AUD1.0b (Public information from Sep 2024)
Share price
CHF35.22
Company register number CH-440.3.000.262-7
Frauenfeld Canton of Thurgau (HQ)
Financials
Estimates*
CHF | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 1.5b | 1.7b | 1.6b | 967m | 1.1b | 1.4b | 1.8b |
% growth | 9 % | 17 % | (7 %) | (40 %) | 13 % | 28 % | 30 % |
EBITDA | (78.0m) | (143m) | (78.0m) | (38.4m) | (45.8m) | 6.0m | 75.1m |
% EBITDA margin | (5 %) | (8 %) | (5 %) | (4 %) | (4 %) | - | 4 % |
Profit | (136m) | (226m) | (171m) | 82.2m | (89.9m) | (55.6m) | (13.6m) |
% profit margin | (9 %) | (13 %) | (11 %) | 9 % | (8 %) | (4 %) | (1 %) |
EV / revenue | 2.0x | 1.6x | 0.5x | 1.2x | 0.7x | 0.6x | 0.5x |
EV / EBITDA | -38.2x | -19.0x | -9.3x | -29.8x | -16.3x | 133.3x | 10.8x |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | €184m Valuation: €800m 1.0x EV/LTM Revenues | IPO |
Total Funding | - |
Related Content
Recent News about Zur Rose Group
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Zur Rose Group
EditACQUISITION by Zur Rose Group Jul 2018